| Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4 L Yi, X Zhou, T Li, P Liu, L Hai, L Tong, H Ma, Z Tao, Y Xie, C Zhang, S Yu, ... Journal of Experimental & Clinical Cancer Research 38, 1-15, 2019 | 113 | 2019 |
| Store-operated Ca2+ entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation M Zhu, L Chen, P Zhao, H Zhou, C Zhang, S Yu, Y Lin, X Yang Journal of Experimental & Clinical Cancer Research 33, 1-11, 2014 | 72 | 2014 |
| Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB (p65) pathway L Hai, C Zhang, T Li, X Zhou, B Liu, S Li, M Zhu, Y Lin, S Yu, K Zhang, ... Cell death & disease 9 (2), 158, 2018 | 71 | 2018 |
| Autophagy suppresses self-renewal ability and tumorigenicity of glioma-initiating cells and promotes Notch1 degradation Z Tao, T Li, H Ma, Y Yang, C Zhang, L Hai, P Liu, F Yuan, J Li, L Yi, ... Cell Death & Disease 9 (11), 1063, 2018 | 53 | 2018 |
| NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathways H Ma, T Li, Z Tao, L Hai, L Tong, L Yi, IR Abeysekera, P Liu, Y Xie, J Li, ... Journal of cellular physiology 234 (2), 1630-1642, 2019 | 48 | 2019 |
| The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required K Zhao, L Wang, T Li, M Zhu, C Zhang, L Chen, P Zhao, H Zhou, S Yu, ... International Journal of Oncology 50 (6), 1989-1999, 2017 | 47 | 2017 |
| Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells C Zhang, L Hai, M Zhu, S Yu, T Li, Y Lin, B Liu, X Zhou, L Chen, P Zhao, ... Oncotarget 8 (20), 33353, 2017 | 41 | 2017 |
| EGFR Amplification Induces Increased DNA Damage Response and Renders Selective Sensitivity to Talazoparib (PARP Inhibitor) in Glioblastoma S Wu, F Gao, S Zheng, C Zhang, E Martinez-Ledesma, R Ezhilarasan, ... Clinical Cancer Research 26 (6), 1395-1407, 2020 | 33 | 2020 |
| The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion T Li, L Yi, L Hai, H Ma, Z Tao, C Zhang, IR Abeysekera, K Zhao, Y Yang, ... Cell Death & Disease 9 (3), 292, 2018 | 32 | 2018 |
| Three-dimensional hydrogel is suitable for targeted investigation of amoeboid migration of glioma cells Y Huang, L Tong, L Yi, C Zhang, L Hai, T Li, S Yu, W Wang, Z Tao, H Ma, ... Molecular medicine reports 17 (1), 250-256, 2018 | 28 | 2018 |
| TMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas J Li, X Wang, L Chen, J Zhang, Y Zhang, X Ren, J Sun, X Fan, J Fan, T Li, ... Cancer gene therapy 29 (8), 1117-1129, 2022 | 22 | 2022 |
| Expression of cortactin in human gliomas and its effect on migration and invasion of glioma cells L Wang, KAI ZhAo, B Ren, M Zhu, C Zhang, P ZhAo, H Zhou, L Chen, ... Oncology reports 34 (4), 1815-1824, 2015 | 22 | 2015 |
| TIE2–FGFR1 interaction induces adaptive PI3K inhibitor resistance by upregulating Aurora A/PlK1/CDK1 signaling in glioblastoma X Li, E Martinez-Ledesma, C Zhang, F Gao, S Zheng, J Ding, S Wu, ... Cancer Research 79 (19), 5088-5101, 2019 | 21 | 2019 |
| Jagged1 is clinically prognostic and promotes invasion of glioma-initiating cells by activating NF-κB (p65) signaling L Hai, P Liu, S Yu, L Yi, Z Tao, C Zhang, IR Abeysekera, T Li, L Tong, ... Cellular Physiology and Biochemistry 51 (6), 2925-2937, 2019 | 16 | 2019 |
| MXRA5 is a novel immune-related biomarker that predicts poor prognosis in glioma JZ Sun, JH Zhang, JB Li, F Yuan, LQ Tong, XY Wang, LL Chen, XG Fan, ... Disease Markers 2021, 1-13, 2021 | 11 | 2021 |
| EGFR suppresses p53 function by promoting p53 binding to DNA-PKcs: a noncanonical regulatory axis between EGFR and wild-type p53 in glioblastoma J Ding, X Li, S Khan, C Zhang, F Gao, S Sen, AR Wasylishen, Y Zhao, ... Neuro-oncology 24 (10), 1712-1725, 2022 | 10 | 2022 |
| A novel prognostic signature based on glioma essential ferroptosis-related genes predicts clinical outcomes and indicates treatment in glioma D Yun, X Wang, W Wang, X Ren, J Li, X Wang, J Liang, J Liu, J Fan, ... Frontiers in Oncology 12, 897702, 2022 | 10 | 2022 |
| BRCA1 identified as a modulator of temozolomide resistance in P53 wild-type GBM using a high-throughput shRNA-based synthetic lethality screening J Ding, S Wu, C Zhang, A Garyali, E Martinez-Ledesma, F Gao, ... American Journal of Cancer Research 9 (11), 2428, 2019 | 10 | 2019 |
| Wild-type TP53 defined gamma-secretase inhibitor sensitivity and synergistic activity with doxorubicin in GSCs C Zhang, E Martinez-Ledesma, F Gao, W Zhang, J Ding, S Wu, X Li, J Wu, ... American Journal of Cancer Research 9 (8), 1734, 2019 | 5 | 2019 |
| Anaplastic pleomorphic xanthoastrocytoma with disseminated growth pattern at the time of diagnosis as well as after treatment: case report and review of literature M Zhu, C Zhang, K Zhao, L Wang, J Sun, Y Feng, W Yao, S Yu, C Sun, ... Chinese Neurosurgical Journal 3, 1-5, 2017 | 4 | 2017 |
Emmanuel Martínez-LedesmaBioinformatics, Tecnológico de Monterrey, Escuela de MedicinaVerified email at tec.mx
